Stock Trading History of Uprichard David C
The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider
Uprichard David C since year 2005.
The trader's CIK number is
1239916.
At the time of this reporting, Uprichard David C is the Director of Alpharma Inc .
(stock ticker symbol
ALO).
See this page for
all insider trading activities at Alpharma Inc .
Note that in the past
UPRICHARD DAVID C also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Uprichard David C since 2005.
| Trade Date |
Symbol |
Company Name (Issuer) |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-03-07 | ALO | Alpharma Inc | Purchase | 500 | 26.30 | 13,152 |
| 2008-03-05 | ALO | Alpharma Inc | Purchase | 500 | 25.02 | 12,507 |
| 2008-02-19 | IVGN | Invitrogen Corp | Sale | 200 | 86.69 | 17,338 |
| 2008-02-13 | IVGN | Invitrogen Corp | Sale | 300 | 86.34 | 25,902 |
| 2007-12-13 | IVGN | Invitrogen Corp | Option Exercise | 2,100 | 72.36 | 151,956 |
| 2007-12-13 | IVGN | Invitrogen Corp | Sale | 2,100 | 94.68 | 198,828 |
| 2007-08-17 | IVGN | Invitrogen Corp | Option Exercise | 400 | 72.36 | 28,944 |
| 2007-06-15 | IVGN | Invitrogen Corp | Sale | 500 | 74.53 | 37,265 |
| 2006-09-12 | CYCC | Xcyte Therapies Inc | Purchase | 320 | 5.87 | 1,878 |
| 2006-09-13 | CYCC | Xcyte Therapies Inc | Purchase | 320 | 6.09 | 1,948 |
| 2006-09-14 | CYCC | Xcyte Therapies Inc | Purchase | 320 | 5.80 | 1,856 |
| 2006-09-08 | CYCC | Xcyte Therapies Inc | Purchase | 250 | 5.69 | 1,422 |
| 2006-09-11 | CYCC | Xcyte Therapies Inc | Purchase | 320 | 5.92 | 1,894 |
| 2006-09-08 | CYCC | Xcyte Therapies Inc | Purchase | 250 | 5.69 | 1,422 |
| 2006-09-11 | CYCC | Xcyte Therapies Inc | Purchase | 320 | 5.92 | 1,894 |
| 2006-09-06 | CYCC | Xcyte Therapies Inc | Purchase | 250 | 4.90 | 1,225 |
| 2006-08-15 | IVGN | Invitrogen Corp | Purchase | 100 | 59.85 | 5,985 |
| 2006-08-11 | IVGN | Invitrogen Corp | Purchase | 100 | 58.97 | 5,897 |
| 2006-08-11 | IVGN | Invitrogen Corp | Purchase | 100 | 58.97 | 5,897 |
| 2006-08-10 | IVGN | Invitrogen Corp | Purchase | 200 | 58.60 | 11,720 |
| 2006-06-06 | IVGN | Invitrogen Corp | Purchase | 100 | 63.26 | 6,326 |
| 2005-04-07 | GLFD | Guilford Pharmaceuticals Inc | Purchase | 2,000 | 2.24 | 4,480 |
| 2005-03-11 | IVGN | Invitrogen Corp | Purchase | 500 | 71.08 | 35,540 |
| 2005-03-09 | IVGN | Invitrogen Corp | Purchase | 500 | 71.08 | 35,540 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Uprichard David C
(Director of Alpharma Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
